AbbVie Inc reports results for the quarter ended June 30 - Earnings Summary

• AbbVie Inc ABBV reported quarterly adjusted earnings of $2.97​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $2.65. The mean expectation of nineteen analysts for the quarter was for earnings of $2.88 per share. Wall Street expected results to range from $2.82 to $3.00 per share.

• Revenue rose 6.6% to $15.42 billion from a year ago; analysts expected $15.03 billion.

• AbbVie Inc's reported EPS for the quarter was 52 cents​.

• The company reported quarterly net income of $938 million.

• AbbVie Inc shares had risen by 2.0% this quarter and gained 6.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 10% in the last three months.​

• In the last 30 days, fourteen analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy," 10 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for AbbVie Inc is $205.00, about 7.7% above its last closing price of $189.31

This summary was machine generated from LSEG data July 31 at 02:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)